Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this session on an overview of short stature and Turner’s syndrome.
Short stature and Turner’s syndrome is caused due to growth hormone deficiency in babies. Short stature is a term applied to a child whose height is 2 standard deviations (SD) or more below the mean for children of that sex and chronologic age. It is a type of deficiency in children that hinders the height of the babies.
Turner syndrome is also a growth deficit condition that affects only females. It occurs when one of the X chromosomes (sex chromosomes) is missing or partially missing in females. Turner syndrome can cause a variety of medical and developmental problems, including short height, failure of the ovaries to develop, and heart defects. Learn about it through various case studies
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer
2.
New CAR T-Cell Therapy Approved for Leukemia
3.
Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment
4.
Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care
5.
Guideline on management of early-stage non-small cell lung cancer released
1.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
2.
Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma
3.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
4.
The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025
5.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
2.
Should We Use DARA Up Front As First-Line Therapy in MM?
3.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation